Literature DB >> 2087489

Systemic or intracranial apomorphine increases copulation in long-term castrated male rats.

L L Scaletta1, E M Hull.   

Abstract

Testosterone or its estrogenic metabolite is thought to be necessary to activate male rat sexual behavior. However, systemic injections of dopamine agonists, alone or in combination with exogenous testosterone, can partially restore copulatory behavior during the prolonged period of its postcastration decline. The present experiments tested the ability of the dopamine agonist apomorphine, injected systemically or into the medial preoptic area (MPOA), to restore copulation in long-term castrates that had failed to copulate on two successive weekly tests. In Experiment 1, systemic injections of apomorphine increased the number of mounts and intromissions in castrated males, compared to vehicle. In castrates given subthreshold testosterone propionate (TP), apomorphine increased the number of mounts. In Experiment 2, microinjections of apomorphine into the MPOA increased the number of mounts in animals without TP. Subthreshold TP had no significant effects in either experiment, either alone or interacting with apomorphine. These results suggest that stimulation of dopamine receptors can partially restore copulation, even after its virtual elimination. Furthermore, dopamine receptors in the MPOA may contribute to sexual arousal in long-term castrates.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2087489     DOI: 10.1016/0091-3057(90)90015-a

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  11 in total

1.  Regulation by the medial amygdala of copulation and medial preoptic dopamine release.

Authors:  J Dominguez; J V Riolo; Z Xu; E M Hull
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

2.  Is sexual motivational state linked to dopamine release in the medial preoptic area?

Authors:  H K Kleitz-Nelson; J M Dominguez; C A Cornil; G F Ball
Journal:  Behav Neurosci       Date:  2010-04       Impact factor: 1.912

3.  Co-localization of mu-opioid and dopamine D1 receptors in the medial preoptic area and bed nucleus of the stria terminalis across seasonal states in male European starlings.

Authors:  Jeremy A Spool; Devin P Merullo; Changjiu Zhao; Lauren V Riters
Journal:  Horm Behav       Date:  2018-11-20       Impact factor: 3.587

Review 4.  Endocrine milieu and erectile dysfunction: is oestradiol-testosterone imbalance, a risk factor in the elderly?

Authors:  Balasubramanian Srilatha; P Ganesan Adaikan
Journal:  Asian J Androl       Date:  2011-03-21       Impact factor: 3.285

5.  Dopamine activates masculine sexual behavior independent of the estrogen receptor alpha.

Authors:  S R Wersinger; E F Rissman
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

Review 6.  Sexual behavior in male rodents.

Authors:  Elaine M Hull; Juan M Dominguez
Journal:  Horm Behav       Date:  2007-04-19       Impact factor: 3.587

7.  Dopamine mediates testosterone-induced social reward in male Syrian hamsters.

Authors:  Margaret R Bell; Cheryl L Sisk
Journal:  Endocrinology       Date:  2013-01-31       Impact factor: 4.736

8.  Androgen- and estrogen-independent regulation of copulatory behavior following castration in male B6D2F1 mice.

Authors:  Jin Ho Park; Paul Bonthuis; Alice Ding; Salehin Rais; Emilie F Rissman
Journal:  Horm Behav       Date:  2009-05-18       Impact factor: 3.587

9.  Species differences in the relative densities of D1- and D2-like dopamine receptor subtypes in the Japanese quail and rats: an in vitro quantitative receptor autoradiography study.

Authors:  Hayley K Kleitz; Charlotte A Cornil; Jacques Balthazart; Gregory F Ball
Journal:  Brain Behav Evol       Date:  2009-03-25       Impact factor: 1.808

10.  The effects of nitric oxide-cGMP pathway stimulation on dopamine in the medial preoptic area and copulation in DHT-treated castrated male rats.

Authors:  Satoru M Sato; Scott R Wersinger; Elaine M Hull
Journal:  Horm Behav       Date:  2007-03-27       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.